Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000312069-25-000516
Filing Date
2025-08-12
Accepted
2025-08-12 16:06:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4145
  Complete submission text file 0000312069-25-000516.txt   6085
Mailing Address 1 CHURCHILL PLACE CANARY WHARF LONDON X0 E14 5HP
Business Address 1 CHURCHILL PLACE CANARY WHARF LONDON X0 E14 5HP 00442031340952
BARCLAYS PLC (Filed by) CIK: 0000312069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)

Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-48577 | Film No.: 251206633
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)